63.28% of Longboard Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Longboard Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/19/2024	Denali Advisors LLC	9,300	$0.20M	0.1%	N/A	0.026%
2/15/2024	Parkman Healthcare Partners LLC	429,892	$2.59M	0.4%	+20.8%	1.802%
2/14/2024	Platinum Investment Management Ltd.	127,048	$0.77M	0.0%	N/A	0.532%
2/13/2024	CIBC Asset Management Inc	212,178	$1.28M	0.0%	+46.8%	0.889%
2/1/2024	Jennison Associates LLC	480,828	$2.90M	0.0%	N/A	2.015%
11/22/2023	Polar Capital Holdings Plc	1,000,000	$5.56M	0.0%	N/A	4.191%
11/15/2023	Laurion Capital Management LP	26,478	$0.15M	0.0%	-14.4%	0.111%
11/13/2023	FMR LLC	2,113,073	$11.75M	0.0%	-17.8%	8.856%
11/1/2023	Bourgeon Capital Management LLC	7,000	$39K	0.0%	N/A	0.030%
10/27/2023	TD Asset Management Inc	121,422	$0.68M	0.0%	+149.8%	0.528%
8/14/2023	Prosight Management LP	734,897	$5.39M	1.7%	-18.4%	3.198%
8/9/2023	TD Asset Management Inc	48,611	$0.36M	0.0%	+29.2%	0.212%
8/4/2023	American International Group Inc.	7,498	$55K	0.0%	N/A	0.033%
8/2/2023	Bank of Montreal Can	15,488	$0.13M	0.0%	N/A	0.067%
5/15/2023	Farallon Capital Management LLC	1,560,500	$5.29M	0.0%	+92.5%	6.795%
5/12/2023	Prosight Management LP	900,600	$3.61M	1.7%	N/A	3.922%
5/9/2023	Integral Health Asset Management LLC	582,000	$2.33M	0.5%	+139.5%	2.534%
4/17/2023	Bourgeon Capital Management LLC	49,855	$0.20M	0.0%	+1,324.4%	0.217%
11/14/2022	Cormorant Asset Management LP	2,118,283	$7.88M	0.6%	-6.8%	15.592%
11/14/2022	Integral Health Asset Management LLC	110,000	$0.41M	0.1%	+91.9%	0.810%
8/3/2022	Integral Health Asset Management LLC	57,335	$0.18M	0.0%	+20.5%	0.422%
5/12/2022	Integral Health Asset Management LLC	47,600	$0.25M	0.1%	+58.7%	0.350%
5/10/2022	TD Asset Management Inc.	37,624	$0.20M	0.0%	-26.0%	0.277%
4/25/2022	Bailard Inc.	21,200	$0.11M	0.0%	N/A	0.156%
2/10/2022	Citigroup Inc.	200,000	$0.97M	0.0%	N/A	1.472%
2/10/2022	TD Asset Management Inc.	50,850	$0.25M	0.0%	-11.2%	0.374%
11/15/2021	Veritable L.P.	20,534	$0.18M	0.0%	N/A	0.151%
11/9/2021	TD Asset Management Inc.	57,275	$0.51M	0.0%	+237.1%	0.421%
8/17/2021	Price T Rowe Associates Inc. MD	2,287,289	$20.11M	0.0%	-0.7%	16.836%
8/16/2021	Alyeska Investment Group L.P.	85,360	$0.78M	0.0%	-31.7%	0.628%
8/13/2021	Renaissance Technologies LLC	10,400	$95K	0.0%	N/A	0.077%
8/13/2021	Laurion Capital Management LP	20,918	$0.19M	0.0%	-14.3%	0.154%
8/13/2021	Integral Health Asset Management LLC	60,000	$0.55M	0.1%	+100.0%	0.442%
8/13/2021	Vanguard Group Inc.	165,545	$1.51M	0.0%	+201.0%	1.218%
8/13/2021	FMR LLC	2,037,831	$18.59M	0.0%	+2.2%	14.999%
5/27/2021	Davidson Kempner Capital Management LP	25,000	$0.41M	0.0%	N/A	0.184%
5/18/2021	Millennium Management LLC	190,349	$3.11M	0.0%	N/A	1.401%
5/18/2021	Orbimed Advisors LLC	300,000	$4.91M	0.0%	N/A	2.208%
5/18/2021	Alyeska Investment Group L.P.	125,000	$2.05M	0.0%	N/A	0.920%
5/18/2021	Cormorant Asset Management LP	2,356,000	$37.19M	0.8%	N/A	17.341%
5/18/2021	Davidson Kempner Capital Management LP	25,000	$0.41M	0.0%	N/A	0.184%
5/18/2021	Citadel Advisors LLC	181,473	$2.96M	0.0%	N/A	1.336%
5/18/2021	Jane Street Group LLC	10,606	$0.17M	0.0%	N/A	0.078%
5/17/2021	Endurant Capital Management LP	16,327	$0.27M	0.1%	N/A	0.120%
5/17/2021	Price T Rowe Associates Inc. MD	2,302,749	$36.23M	0.0%	N/A	16.949%
5/17/2021	Goldman Sachs Group Inc.	25,000	$0.41M	0.0%	N/A	0.184%
5/14/2021	Laurion Capital Management LP	24,400	$0.40M	0.0%	N/A	0.180%
5/14/2021	TD Asset Management Inc.	16,993	$0.28M	0.0%	N/A	0.100%
5/13/2021	Citigroup Inc.	405,645	$6.62M	0.0%	N/A	2.398%

Data available starting January 2016

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. The company develops bexicaserin (LP352), which has completed Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. It also develops LP659, an S1P receptor modulator for the treatment of neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Today's Range

Now: $19.72

$18.87

$20.00

50 Day Range

MA: $20.04

$17.00

$23.94

52 Week Range

Now: $19.72

$3.60

$28.15

Volume

179,169 shs

Average Volume

371,648 shs

Market Capitalization

$710.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24

Who are the company insiders with the largest holdings of Longboard Pharmaceuticals?: Longboard Pharmaceuticals' top insider investors include:
Arena Pharmaceuticals Inc (Major Shareholder)
Learn More about top insider investors at Longboard Pharmaceuticals.
Who are the major institutional investors of Longboard Pharmaceuticals?: Longboard Pharmaceuticals' top institutional shareholders include:
Denali Advisors LLC — 0.03%
Learn More about top institutional investors of Longboard Pharmaceuticals stock.
Which major investors are buying Longboard Pharmaceuticals stock?: In the previous quarter, LBPH stock was purchased by institutional investors including:
Denali Advisors LLC

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here

LBPH Insider Trading

Longboard Pharmaceuticals Insider Trading History Chart

Longboard Pharmaceuticals Share Price & Price History

Longboard Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Longboard Pharmaceuticals (NASDAQ:LBPH)